Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore's MinION™ Platform
This cutting-edge technology is set to help clinical laboratories in the field of genetic marker assessment, providing an unprecedented level of accuracy at a competitive pricing structure.
- This cutting-edge technology is set to help clinical laboratories in the field of genetic marker assessment, providing an unprecedented level of accuracy at a competitive pricing structure.
- As a result, many laboratories have relied on molecular techniques such as SSOP or RT-PCR, with lower resolution.
- NanoTYPE MONO enables labs of all sizes and budgets to enhance their genetic testing capabilities while seamlessly integrating with the compact and environmentally friendly MinION system.
- To learn more about NanoTYPE MONO and its transformative capabilities for clinical laboratories, please visit www.omixon.com/products/nanotype-mono/